Moderna said on Thursday (Aug 17) an initial study data showed its updated Covid-19 vaccine to be effective against the “Eris” and “Fornax” subvariants in humans. The company expects the updated shot to be available, pending approval from health regulators in the United States, Europe and elsewhere, in the coming weeks for the fall vaccination
Read More
About The Author
